RGEN Latest News

Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference

globenewswire.com — May 7, 2026

WALTHAM, Mass. , May 07, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology lead

Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises

zacks.com — May 6, 2026

RGEN tops Q1 earnings and revenue estimates, sending shares higher as strong chromatography and analytics business aid growth. The company raises its

Repligen Corporation (RGEN) Q1 2026 Earnings Call Transcript

seekingalpha.com — May 5, 2026

Repligen Corporation (RGEN) Q1 2026 Earnings Call Transcript

Repligen (RGEN) Q1 Earnings and Revenues Beat Estimates

zacks.com — May 5, 2026

Repligen (RGEN) came out with quarterly earnings of $0. 48 per share, beating the Zacks Consensus Estimate of $0.

Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

globenewswire.com — May 5, 2026

WALTHAM, Mass. , May 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology lead